LadRx

LadRx Current Ratio

The Current Ratio of LadRx (LADX) as of Oct 24, 2026 is 0.05. In the previous year, Current Ratio was 0.13 — a change of -63.72% (lower).

Current Ratio

0.05

YoY

-63.72%

Last updated:

Current Ratio of LadRx is 2024 0.05 . Current Ratio of LadRx was 2023 0.13 . It decreases by -63.72% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LadRx Stock analysis

What does LadRx do? CytRx Corp. focuses on developing aldoxorubicin, a modified doxorubicin for cancer treatment, currently in Phase III trials for soft tissue sarcoma and multiple other cancer indications. The company generates revenue through clinical trial partnerships and potential future drug sales, targeting pharmaceutical companies and healthcare providers who require novel oncology treatments. CytRx's primary product, aldoxorubicin, is being evaluated in various cancer types including small cell lung cancer and glioblastoma, with additional pre-clinical development for DK049, an anti-cancer drug conjugate using LADR technology. The firm's revenue streams are derived from its clinical development programs and potential licensing agreements with partners in the oncology sector. LadRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LadRx stock

Current Ratio of LadRx is 0.05 in 2024.

Current Ratio of LadRx changed from 0.13 to 0.05, representing a -63.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio LadRx since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's LadRx with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — LadRx

All Key Metrics — LadRx